CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Randomized phase III trial of irinotecan plus cisplatin versus irinotecan alone after S-1 based chemotherapy failure for patients with advanced and recurrent gastric cancer (AGC) (TCOG GI-0801).
Author
Eisaku Sasaki
Ichinosuke Hyodo
+18Â more
Katsuhiko Higuchi
Kazuhito Yajima
Ken Nishimura
Ken Shimada
Kenji Amagai
Kouji Kobayashi
Naoshi Hosaka
Norisuke Nakayama
Satoshi Tanabe
Takashi Sekikawa
Tatsu Shimoyama
Tohru Sasaki
Toshikazu Moriwaki
Toshikazu Sakuyama
Wasaburo Koizumi
Yoshiharu Maeda
Yuiti Takeda
Yusuke Saito
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref